{"id":143493,"date":"2026-01-04T02:00:16","date_gmt":"2026-01-04T02:00:16","guid":{"rendered":"http:\/\/cryptospotters.net\/?p=143493"},"modified":"2026-01-04T02:00:16","modified_gmt":"2026-01-04T02:00:16","slug":"mindrank-in-phase-3-trial-with-chinas-first-ai-assisted-new-drug-cutting-rd-costs-by-60","status":"publish","type":"post","link":"http:\/\/cryptospotters.net\/?p=143493","title":{"rendered":"MindRank in Phase 3 trial with China\u2019s first AI-assisted new drug, cutting R&amp;D costs by 60%"},"content":{"rendered":"<p>Source: Tech &#8211; South China Morning PostHangzhou-based biotech start-up MindRank has progressed to Phase 3 clinical trials for its weight-loss drug, making it China\u2019s first artificial intelligence-assisted Category 1 new drug to reach this stage.<br \/>\nMindRank announced last month that it had initiated a Phase 3 clinical trial in China for MDR-001, a small molecule GLP-1 receptor agonists designed with the help of AI. GLP-1 receptor agonists mimic natural hormones to regulate blood sugar and appetite.<br \/>\nAccording to Niu Zhangming, MindRank\u2019s&#8230;<a href=\"https:\/\/www.scmp.com\/tech\/tech-trends\/article\/3338618\/mindrank-phase-3-trial-chinas-first-ai-assisted-new-drug-cutting-rd-costs-60?utm_source=rss_feed\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Source: Tech &#8211; South China Morning PostHangzhou-based biotech start-up MindRank has progressed to Phase 3 clinical trials for its weight-loss drug, making it China\u2019s first artificial intelligence-assisted Category 1 new&hellip; <\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[4],"tags":[],"_links":{"self":[{"href":"http:\/\/cryptospotters.net\/index.php?rest_route=\/wp\/v2\/posts\/143493"}],"collection":[{"href":"http:\/\/cryptospotters.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/cryptospotters.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"http:\/\/cryptospotters.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=143493"}],"version-history":[{"count":0,"href":"http:\/\/cryptospotters.net\/index.php?rest_route=\/wp\/v2\/posts\/143493\/revisions"}],"wp:attachment":[{"href":"http:\/\/cryptospotters.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=143493"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/cryptospotters.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=143493"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/cryptospotters.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=143493"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}